Radiotherapy may exacerbated anti‐programmed cell death 1 treatment induced vitiligo: A case report
Abstract Immunotherapy with programmed cell death 1 (PD‐1) checkpoint inhibitors combined with chemoradiotherapy shows great potential for cancer treatment and is getting extensively researched. However, a plethora of immune‐related adverse events (irAEs) has been observed during anti‐PD‐1 treatment...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-02-01
|
| Series: | Skin Health and Disease |
| Online Access: | https://doi.org/10.1002/ski2.287 |